HTLV-1

Findings by UMN Researchers Could Help Fight Cancer

Interdisciplinary researchers from the Institute for Molecular Virology (IMV) have made a key discovery that could help fight Human T-cell leukemia virus type (HTLV-1).

HTLV-1 is a rare but extremely infectious virus spreading among remote areas of central Australia. The virus produces particles that can then spread to other cells in the body. University of Minnesota researchers, including Louis Mansky, PhD, director of the IMV and professor in the School of Dentistry, and his team, created mutations in HTLV-1’s main structural protein (called Gag) and investigated how these mutants affected the production of HTLV-1 particles.

“By creating these mutants, we found important new insights regarding how the structure of the Gag protein is critically important in making new virus particles,” said Mansky, the lead author of the study.

Read the full story.

Other News

Sara Busche and Adebayo Ibikunle
They have been working with the Mobile Health Initiative to create resource guides and practices to share with providers to use with…
20 Years of HERO
We are filled with profound gratitude and admiration for the incredible work accomplished over the years.
Nhi Lang, Claire Nash, and Margaret Perry
They're working to extrapolate outcome measure data to determine the effectiveness of treatments.